Involvement of senescence marker protein-30 in glucose metabolism disorder and non-alcoholic fatty liver disease

Geriatrics and Gerontology International

Volumn 16, Issue , 2016, Pages 4-16

  Kondo, Yoshitaka ^a,b   Ishigami, Akihito ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Aging; Diabetes mellitus; Non alchoholic fatty liver disease; Senescence marker protein 30; VitaminC

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); APOLIPOPROTEIN B; ASCORBIC ACID; BILE ACID; CALCIUM ION; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE; MESSENGER RNA; REGUCALCIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; VERY LOW DENSITY LIPOPROTEIN; CALCIUM BINDING PROTEIN; RGN PROTEIN, HUMAN; SIGNAL PEPTIDE;

ASCORBIC ACID DEFICIENCY; BILE ACID SYNTHESIS; CALCIUM TRANSPORT; DIABETIC NEPHROPATHY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME DEFECT; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; KIDNEY INJURY; KNOCKOUT MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VITAMIN METABOLISM; AGING; ANIMAL; APOPTOSIS; DISORDERS OF CARBOHYDRATE METABOLISM; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AGING; ANIMALS; APOPTOSIS; CALCIUM-BINDING PROTEINS; GLUCOSE METABOLISM DISORDERS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS;

EID: 84961677965     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/ggi.12722     Document Type: Review

References (78)

1. Fujita T, Uchida K, Maruyama N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta 1992; 1116: 122-128.
2. Ishigami A, Maruyama N. Significance of SMP30 in gerontology. Geriatr Gerontol Int 2007; 7: 316-325.
3. Fujita T, Shirasawa T, Inoue H, Kitamura T, Maruyama N. Hepatic and renal expression of senescence marker protein-30 and its biological significance. J Gastroenterol Hepatol 1998; 13: S124-S131.
4. Mori T, Ishigami A, Seyama K etal. Senescence marker protein-30 knockout mouse as a novel murine model of senile lung. Pathol Int 2004; 54: 167-173.
5. Ishigami A, Masutomi H, Handa S, Maruyama N. Age-associated decrease of senescence marker protein-30/gluconolactonase in individual mouse liver cells: immunohistochemistry and immunofluorescence. Geriatr Gerontol Int 2015; 15: 804-810.
6. Kagami Y, Kondo Y, Handa S, Maruyama N, Ishigami A. Senescence marker protein-30/gluconolactonase expression in the mouse ovary during gestation. Biol Pharm Bull 2013; 36: 2005-2008.
7. Maruyama N, Ishigami A, Kondo Y. Pathophysiological significance of senescence marker protein-30. Geriatr Gerontol Int 2010; 10 (Suppl 1): S88-S98.
8. Fujita T, Mandel JL, Shirasawa T, Hino O, Shirai T, Maruyama N. Isolation of cDNA clone encoding human homologue of senescence marker protein-30 (SMP30) and its location on the X chromosome. Biochim Biophys Acta 1995; 1263: 249-252.
9. Ishigami A, Fujita T, Handa S etal. Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-α- and Fas-mediated apoptosis. Am J Pathol 2002; 161: 1273-1281.
10. Ishigami A, Kondo Y, Nanba R etal. SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem Biophys Res Commun 2004; 315: 575-580.
11. 2+-pumping activity in Hep G2 cells. Biochem Biophys Res Commun 1998; 250: 374-380.
12. Inoue H, Fujita T, Kitamura T etal. Senescence marker protein-30 (SMP30) enhances the calcium efflux from renal tubular epithelial cells. Clin Exp Nephrol 1999; 3: 261-267.
13. 2+ pump by cyclic nucleotides in cultured vascular smooth muscle cells. J Biol Chem 1988; 263: 8058-8065.
14. Reuter H, Seitz N. The dependence of calcium efflux from cardiac muscle on temperature and external ion composition. J Physiol 1968; 195: 451-470.
15. Barry WH, Rasmussen CA Jr, Ishida H, Bridge JH. External Na-independent Ca extrusion in cultured ventricular cells. Magnitude and functional significance. J Gen Physiol 1986; 88: 393-411.
16. Inai Y, Ohta Y, Nishikimi M. The whole structure of the human nonfunctional L-gulono-γ-lactone oxidase gene-the gene responsible for scurvy- and the evolution of repetitive sequences thereon. J Nutr Sci Vitaminol (Tokyo) 2003; 49: 315-319.
17. Nishikimi M, Yagi K. Molecular basis for the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis. Am J Clin Nutr 1991; 54: 1203S-1208S.
18. Kondo Y, Inai Y, Sato Y etal. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci U S A 2006; 103: 5723-5728.
19. Sato T, Seyama K, Sato Y etal. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med 2006; 174: 530-537.
20. Koike K, Kondo Y, Sekiya M etal. Complete lack of vitamin C intake generates pulmonary emphysema in senescence marker protein-30 knockout mice. Am J Physiol Lung Cell Mol Physiol 2010; 298: L784-L792.
21. Koike K, Ishigami A, Sato Y etal. Vitamin C prevents cigarette smoke-induced pulmonary emphysema in mice and provides pulmonary restoration. Am J Respir Cell Mol Biol 2014; 50: 347-357.
22. Ishikawa Y, Hashizume K, Kishimoto S etal. Effect of vitamin C depletion on UVR-B induced cataract in SMP30/GNL knockout mice. Exp Eye Res 2012; 94: 85-89.
23. Sato Y, Arai KY, Nishiyama T etal. Ascorbic acid deficiency leads to epidermal atrophy and UVB-induced skin pigmentation in SMP30/GNL knockout hairless mice. J Invest Dermatol 2012; 132: 2112-2115.
24. Arai KY, Sato Y, Kondo Y etal. Effects of vitamin C deficiency on the skin of the senescence marker protein-30 (SMP30) knockout mouse. Biochem Biophys Res Commun 2009; 385: 478-483.
25. Amano A, Tsunoda M, Aigaki T, Maruyama N, Ishigami A. Effect of ascorbic acid deficiency on catecholamine synthesis in adrenal glands of SMP30/GNL knockout mice. Eur J Nutr 2014; 53: 177-185.
26. Kondo Y, Sasaki T, Sato Y etal. Vitamin C depletion increases superoxide generation in brains of SMP30/GNL knockout mice. Biochem Biophys Res Commun 2008; 377: 291-296.
27. Sato Y, Kajiyama S, Amano A etal. Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun 2008; 375: 346-350.
28. Kondo Y, Sakuma R, Ichisawa M etal. Potato chip intake increases ascorbic acid levels and decreases reactive oxygen species in SMP30/GNL knockout mouse tissues. J Agric Food Chem 2014; 62: 9286-9295.
29. Sato Y, Amano A, Kishimoto Y etal. Ascorbic acid prevents protein oxidation in livers of senescence marker protein-30/gluconolactonase knockout mice. Geriatr Gerontol Int 2014; 14: 989-995.
30. Amano A, Aigaki T, Maruyama N, Ishigami A. Ascorbic acid depletion enhances expression of the sodium-dependent vitamin C transporters, SVCT1 and SVCT2, and uptake of ascorbic acid in livers of SMP30/GNL knockout mice. Arch Biochem Biophys 2010; 496: 38-44.
31. Kishimoto Y, Kanai T, Sato K etal. Insufficient ascorbic acid intake during gestation induces abnormal cardiac dilation in fetal and neonatal SMP30/GNL knockout mice. Pediatr Res 2013; 73: 578-584.
32. Takahashi K, Kishimoto Y, Konishi T etal. Ascorbic acid deficiency affects genes for oxidation-reduction and lipid metabolism in livers from SMP30/GNL knockout mice. Biochim Biophys Acta 2014; 1840: 2289-2298.
33. Davis RA, Miyake JH, Hui TY, Spann NJ. Regulation of cholesterol-7α-hydroxylase: BAREly missing a SHP. J Lipid Res 2002; 43: 533-543.
34. Gunasekaran U, Gannon M. Type 2 diabetes and the aging pancreatic beta cell. Aging (Albany NY) 2011; 3: 565-575.
35. Hasegawa G, Yamasaki M, Kadono M etal. Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion. Endocrinology 2010; 151: 529-536.
36. Hasegawa G. Decreased senescence marker protein-30 could be a factor that contributes to the worsening of glucose tolerance in normal aging. Islets 2010; 2: 258-260.
37. Prentki M, Matschinsky FM, Madiraju SR. Metabolic signaling in fuel-induced insulin secretion. Cell Metab 2013; 18: 162-185.
38. Banerjee S, Ghosh NC. Relation of scurvy to glucose tolerance test, liver glycogen, and insulin content of pancreas of guinea pigs. J Biol Chem 1947; 168: 207-211.
39. Wells WW, Dou CZ, Dybas LN, Jung CH, Kalbach HL, Xu DP. Ascorbic acid is essential for the release of insulin from scorbutic guinea pig pancreatic islets. Proc Natl Acad Sci U S A 1995; 92: 11869-11873.
40. Dou C, Xu DP, Wells WW. Studies on the essential role of ascorbic acid in the energy dependent release of insulin from pancreatic islets. Biochem Biophys Res Commun 1997; 231: 820-822.
41. Senmaru T, Yamazaki M, Okada H etal. Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice. J Clin Biochem Nutr 2012; 50: 114-118.
42. Jung CH, Wells WW. Ascorbic acid is a stimulatory cofactor for mitochondrial glycerol-3-phosphate dehydrogenase. Biochem Biophys Res Commun 1997; 239: 457-462.
43. Wells WW, Xu DP, Washburn MP, Cirrito HK, Olson LK. Polyhydroxybenzoates inhibit ascorbic acid activation of mitochondrial glycerol-3-phosphate dehydrogenase: implications for glucose metabolism and insulin secretion. J Biol Chem 2001; 276: 2404-2410.
44. Fineberg D, Jandeleit-Dahm KA, Cooper ME. Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol 2013; 9: 713-723.
45. Yumura W, Imasawa T, Suganuma S etal. Accelerated tubular cell senescence in SMP30 knockout mice. Histol Histopathol 2006; 21: 1151-1156.
46. Okada H, Senmaru T, Fukui M etal. Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes. J Diabetes Investig 2015; 6: 35-43.
47. Haase VH. Pathophysiological Consequences of HIF Activation: HIF as a modulator of fibrosis. Ann N Y Acad Sci 2009; 1177: 57-65.
48. Higgins DF, Kimura K, Bernhardt WM etal. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 3810-3820.
49. Wada T, Furuichi K, Sakai N etal. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000; 58: 1492-1499.
50. Zubiri I, Posada-Ayala M, Benito-Martin A etal. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes. Transl Res 2015; 166: 474-484.
51. Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA 2015; 313: 2263-2273.
52. Yeh MM, Brunt EM. Pathological features of fatty liver disease. Gastroenterology 2014; 147: 754-764.
53. Yki-Jarvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2014; 2: 901-910.
54. Park H, Ishigami A, Shima T etal. Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease. J Gastroenterol 2010; 45: 426-434.
55. Adiels M, Boren J, Caslake MJ etal. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler Thromb Vasc Biol 2005; 25: 1697-1703.
56. Adiels M, Taskinen MR, Packard C etal. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006; 49: 755-765.
57. Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18: 2300-2308.
58. Nagarajan P, Mahesh Kumar MJ, Venkatesan R, Majundar SS, Juyal RC. Genetically modified mouse models for the study of nonalcoholic fatty liver disease. World J Gastroenterol 2012; 18: 1141-1153.
59. Sanches SC, Ramalho LN, Augusto MJ, da Silva DM, Ramalho FS. Nonalcoholic steatohepatitis: a search for factual animal models. Biomed Res Int 2015; 2015: 574832.
60. Y/-) exhibit increases in small dense-LDL and severe fatty liver despite being fed a standard diet. PLoS ONE 2013; 8: e65698.
61. Fukui M, Senmaru T, Hasegawa G etal. 17β-Estradiol attenuates saturated fatty acid diet-induced liver injury in ovariectomized mice by up-regulating hepatic senescence marker protein-30. Biochem Biophys Res Commun 2011; 415: 252-257.
62. Park JY, Seong JK, Paik YK. Proteomic analysis of diet-induced hypercholesterolemic mice. Proteomics 2004; 4: 514-523.
63. Zhang L, Perdomo G, Kim DH etal. Proteomic analysis of fructose-induced fatty liver in hamsters. Metabolism 2008; 57: 1115-1124.
64. Ahmed AA, Balogun KA, Bykova NV, Cheema SK. Novel regulatory roles of omega-3 fatty acids in metabolic pathways: a proteomics approach. Nutr Metab (Lond) 2014; 11: 6.
65. Handa S, Maruyama N, Ishigami A. Over-expression of Senescence Marker Protein-30 decreases reactive oxygen species in human hepatic carcinoma Hep G2 cells. Biol Pharm Bull 2009; 32: 1645-1648.
66. Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol 2008; 4: 278-286.
67. Imamura Y, Noda S, Hashizume K etal. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A 2006; 103: 11282-11287.
68. Hashizume K, Hirasawa M, Imamura Y etal. Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am J Pathol 2008; 172: 1325-1331.
69. Murakami K, Inagaki J, Saito M etal. Skin atrophy in cytoplasmic SOD-deficient mice and its complete recovery using a vitamin C derivative. Biochem Biophys Res Commun 2009; 382: 457-461.
70. Nojiri H, Saita Y, Morikawa D etal. Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking. J Bone Miner Res 2011; 26: 2682-2694.
71. Murakami K, Murata N, Noda Y etal. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid beta protein oligomerization and memory loss in mouse model of Alzheimer disease. J Biol Chem 2011; 286: 44557-44568.
72. Noda Y, Ota K, Shirasawa T, Shimizu T. Copper/zinc superoxide dismutase insufficiency impairs progesterone secretion and fertility in female mice. Biol Reprod 2012; 86: 1-8.
73. Kojima T, Wakamatsu TH, Dogru M etal. Age-related dysfunction of the lacrimal gland and oxidative stress: evidence from the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice. Am J Pathol 2012; 180: 1879-1896.
74. Olofsson EM, Marklund SL, Behndig A. Enhanced age-related cataract in copper-zinc superoxide dismutase null mice. Clin Experiment Ophthalmol 2012; 40: 813-820.
75. Elchuri S, Oberley TD, Qi W etal. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005; 24: 367-380.
76. Muller FL, Song W, Liu Y etal. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic Biol Med 2006; 40: 1993-2004.
77. Uchiyama S, Shimizu T, Shirasawa T. CuZn-SOD deficiency causes ApoB degradation and induces hepatic lipid accumulation by impaired lipoprotein secretion in mice. J Biol Chem 2006; 281: 31713-31719.
78. Kondo Y, Masutomi H, Noda Y etal. Senescence marker protein-30/superoxide dismutase 1 double knockout mice exhibit increased oxidative stress and hepatic steatosis. FEBS Open Bio 2014; 4: 522-532.